Updates in Glycemic Management in the Hospital

Curr Diab Rep. 2019 Nov 20;19(11):133. doi: 10.1007/s11892-019-1274-7.

Abstract

Purpose of review: To provide an update of glycemic management during metabolic stress related to surgery or critical illness.

Recent findings: There is a clear association between severe hyperglycemia, hypoglycemia, and high glycemic variability and poor outcomes of postoperative or critically ill patients. However, the impressive beneficial effects of tight glycemic management (TGM) by intensive insulin therapy reported in one study were never reproduced. Hence, the recommendation of TGM is now replaced by more liberal blood glucose (BG) targets (< 180 mg/dL or 10 mM). Recent data support the concept of targeting individualized blood glucose (BG) values according to the presence of diabetes mellitus/chronic hyperglycemia, the presence of brain injury, and the time from injury. A more liberal glycemic management goal is currently advised during metabolic stress and could be switched to individualized glycemic management once validated by prospective trials.

Keywords: Critically ill; Glucose; Insulin; Insulin resistance; Postoperative care; Stress hyperglycemia.

Publication types

  • Review

MeSH terms

  • Blood Glucose
  • Critical Illness
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hyperglycemia* / drug therapy
  • Hypoglycemia* / drug therapy
  • Hypoglycemic Agents* / therapeutic use
  • Inpatients
  • Insulin
  • Prospective Studies

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin